Practical management of patients with relapsed/refractory multiple myeloma receiving talquetamab, a GPRC5DxCD3 bispecific antibody: experience in monumenTAL-1

被引：0

作者：

Catamero, Donna ^{[1
]}

Purcell, Kiah ^{[2
]}

Ray, Chloe ^{[2
]}

Giacoia, Leora ^{[2
]}

Leahey, Sheryl ^{[3
]}

Born, Patricia ^{[4
]}

Kruyswijk, Sandy ^{[5
]}

机构：

[1] Mt Sinai Hlth Syst, New York, NY USA

[2] Mt Sinai Sch Med, New York, NY USA

[3] City Hope Natl Med Ctr, Duarte, CA USA

[4] Univ Hosp Wurzburg, Wurzburg, Germany

[5] Univ Amsterdam, Med Ctr, Amsterdam, Netherlands

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

NSP-03

引用

页码：S314 / S315

页数：2

共 50 条

[41] RG6234, a GPRC5DxCD3 T-Cell Engaging Bispecific Antibody, Is Highly Active in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Updated Intravenous (IV) and First Subcutaneous (SC) Results from a Phase I Dose-Escalation Study
Carlo-Stella, Carmelo
Mazza, Rita
Manier, Salomon
Facon, Thierry
Yoon, Sung-Soo
Koh, Youngil
Harrison, Simon J.
Er, Jeremy
Pinto, Antonio
Volzone, Francesco
Perrone, Giulia
Corradini, Paolo
Cazaubiel, Titouan
Hulin, Cyrille
Touzeau, Cyrille
Moreau, Philippe
Ocio, Enrique M.
Gaisan, Carmen Maria Montes
Popat, Rakesh
Leong, Sarah
Offner, Fritz
Otero, Paula Rodriguez
Alfonso-Pierola, Ana
Broeske, Ann-Marie E.
Dekhtiarenko, Iryna
Helms, Hans-Joachim
Belli, Sara
Rossmann, Eva
Fauti, Tanja
Eckmann, Jan
Moore, Tom
Schneider, Meike
Jacob, Wolfgang
Weisser, Martin
Hutchings, Martin
Riley, Caroline Hasselbalch
BLOOD, 2022, 140
[42] A Phase 1, First-in-Human Study of Talquetamab, a G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) x CD3 Bispecific Antibody, in Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM)
Chari, Ajai
Berdeja, Jesus G.
Oriol, Albert
van de Donk, Niels W. C. J.
Rodriguez, Paula
Askari, Elham
Mateos, Maria-Victoria
Minnema, Monique C.
Verona, Raluca
Girgis, Suzette
Prior, Thomas
Hilder, Brandi W.
Russell, Jeffery
Goldberg, Jenna D.
Krishnan, Amrita
BLOOD, 2020, 136
[43] Talquetamab vs Real-World Physician's Choice in Patients With Relapsed/Refractory Multiple Myeloma and Prior B-Cell Maturation Antigen Therapy: Analyses of MonumenTAL-1 vs LocoMMotion/MoMMent
Mateos Manteca, Maria-Victoria
Jakubowiak, Andrzej
Einsele, Hermann
Schinke, Carolina
Besemer, Britta
Anguille, Sebastien
Manier, Salomon
Rasche, Leo
Goldschmidt, Hartmut
van de Donk, Niels
Perrot, Aurore
Teipel, Raphael
Karlin, Lionel
Scheid, Christof
San-Miguel, Jesus
Pawlyn, Charlotte
Martinez-Lopez, Joaquin
Cavo, Michele
Diels, Joris
Renaud, Thomas
Orel, Oleksiy
Cabrieto, Jedelyn
Perualila, Nolen
Weisel, Katja
Moreau, Philippe
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S69 - S70
[44] Efficacy and safety of talquetamab, a G protein-coupled receptor family C group 5 member D x CD3 bispecific antibody, in patients with relapsed/refractory multiple myeloma (RRMM): Updated results from MonumenTAL-1.
Minnema, Monique C.
Krishnan, Amrita Y.
Berdeja, Jesus G.
Rocafiguera, Albert Oriol
van de Donk, Niels W. C. J.
Rodriguez-Otero, Paula
Morillo, Daniel
Mateos, Maria-Victoria
Costa, Luciano J.
Caers, Jo
Vishwamitra, Deeksha
Ma, Joanne
Yang, Shiyi
Hilder, Brandi
Tolbert, Jaszianne A.
Goldberg, Jenna D.
Chari, Ajai
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[45] Analysis of infections and parameters of humoral immunity in patients (pts) with relapsed/refractory multiple myeloma (RRMM) treated with talquetamab (tal) monotherapy in MonumenTAL-1.
Rodriguez-Otero, Paula
Schinke, Carolina D.
Chari, Ajai
Lipe, Brea
Lavi, Noa
Rasche, Leo
Vishwamitra, Deeksha
Skerget, Sheri
Verona, Raluca
Ma, Xuewen
Khedkar, Sheetal
Hilder, Brandi
Masterson, Tara J.
Campagna, Michela
Renaud, Thomas
Tolbert, Jaszianne A.
Heuck, Christoph
Smit, Marie-Anne Damiette
van de Donk, Niels W. C. J.
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[46] Talquetamab, a G protein-coupled receptor family C group 5 member D (GPRC5D)xCD3 bispecific antibody, in relapsed/refractory multiple myeloma (RRMM): Updated results of a phase 1, first-in-human study
Van De Donk, Niels W. C. J.
Krishnan, Amrita
Oriol, A.
Berdeja, Jesus G.
Rodriguez-Otero, Paula
Askari, Elham
Mateos, Maria-Victoria
Minnema, Monique C.
Costa, Luciano
Verona, Raluca
Girgis, Suzette
Prior, Thomas
Hilder, Brandi
Russell, Jeffery
Goldberg, Jenna
Chari, Ajai
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S16 - S17
[47] Prophylactic Dexamethasone and Remote Monitoring for Patients with Relapsed Refractory Multiple Myeloma (RRMM) Receiving Bispecific Antibodies (BsAb): Experience at a Single Institution
Varga, Cindy
Ahmed, Ferdous
Knight, Marvin
Bhutani, Manisha
Paul, Barry
Atrash, Shebli
Voorhees, Peter M.
Ferreri, Christopher
BLOOD, 2024, 144 : 4720 - 4721
[48] Updated results of a phase 1, first-in-human study of talquetamab, a G protein-coupled receptor family C group 5 member D (GPRC5D) x CD3 bispecific antibody, in relapsed/refractory multiple myeloma (MM).
Berdeja, Jesus G.
Krishnan, Amrita Y.
Oriol, Albert
van de Donk, Niels W. C. J.
Rodriguez-Otero, Paula
Askari, Elham
Mateos, Maria-Victoria
Minnema, Monique C.
Costa, Luciano J.
Verona, Raluca
Girgis, Suzette
Prior, Thomas
Hilder, Brandi
Russell, Jeffery Scott
Goldberg, Jenna D.
Chari, Ajai
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[49] Lbl-034, a Highly Differentiated T-Cell Engaging Bispecific Antibody Targeting GPRC5D for the Treatment of Relapsed or Refractory Multiple Myeloma
Wang, Baohui
Huang, Xiao
Sun, Jianming
Qin, Yurong
Shang, Hongyan
Li, Tingting
Wu, Guojin
Chen, Min
Wang, Hailin
Zhang, Peng
Jiang, Duqing
Liu, Tongjun
Ye, Mi
Cai, Shengli
Lai, Shoupeng
Kang, Xiaoqiang
Ling, Hong
BLOOD, 2023, 142
[50] Talquetamab plus Pomalidomide in Patients with Relapsed/Refractory Multiple Myeloma: Safety and Preliminary Efficacy Results from the Phase 1b MonumenTAL-2 Study
Matous, Jeffrey
Biran, Noa
Perrot, Aurore
Berdeja, Jesus G.
Dorritie, Kathleen
Van Elssen, Janine
Searle, Emma
Touzeau, Cyrille
Anguille, Sebastien
Vishwamitra, Deeksha
Nguyen, Ashley
Ghosh, Debopriya
Shearin, Elizabeth
Thornton, Katherine
Smit, Damiette
Quach, Hang
BLOOD, 2023, 142

← 1 2 3 4 5 →